Guangdong Marubi Biotechnology Co.,Ltd.’s Net Profit Dropped 30.6% in 2022
Listen to the full version

Guangdong Marubi Biotechnology Co.,Ltd. (广东丸美生物技术股份有限公司) (603983.SH) reported a net profit of 167.4 million yuan in 2022, down 30.6% year-on-year.
Meanwhile, the company posted 1.7 billion yuan in revenue, down 3.1% year-on-year.
At the end of the reporting period, it had 4.1 billion yuan in total assets and 838.6 million yuan in total liabilities, with a liability-to-asset ratio of 20.5%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR